4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001493152-24-031378
CFO and Interim CEO bought 14,400 shares at $1.01 ($14,544)
From the SEC's structured data for this filing
Trades in this filing
Mack Gene · CFO and Interim CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-09 | Purchase : show line 1 in the form | +14,400 | $1.01 | $14,544 | 14,400 | D |
| Open-market purchases · 14,400 sh · avg $1.01 · $14,544 | ||||||
Loading xslF345X05/ownership.xml…